Patents
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
06/2009
06/25/2009US20090163547 Indene derivatives, their preparation and use as medicaments
06/25/2009US20090163496 Antibacterial agents
06/24/2009CN101462988A Technique for synthesizing bicalutamide
06/24/2009CN100502847C Compositions containing substituted quinolines and substituted diphenyl sulfones and its pharmaceutical use
06/23/2009US7550505 Such as N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-3-(naphthalen-1-ylsulfonyl)propanamide; acne, seborrhea, hirsutism, alopecia, hidradenitis suppurativa; prostate cancer
06/18/2009WO2009010156A3 Substituted phenylpropoargyl compounds, methods for the production thereof, and use of same as herbicides and plant growth regulators
06/18/2009US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction
06/18/2009US20090155929 Methods for detection of hydrophobic drugs
06/18/2009US20090155481 Low protonation constant hydroxy acids
06/17/2009EP2069294A1 Soluble epoxide hydrolase inhibitors
06/17/2009EP1565431B1 Cannabinoid receptor ligands
06/17/2009CN100500651C Crystalline and pure modafinil and process of preparing the same
06/16/2009US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders
06/16/2009US7547716 Sulfonamide derivatives
06/16/2009US7547701 cathepsin S inhibitors; e.g. N-(1-cyanocyclopropyl)-3-phenylmethanesulfonyl-2-(2,2,2-trifluoro-1-phenylethylamino)-propionamide; autoimmune diseases such as rheumatoid arthritis or multiple sclerosis, pain, or atherosclerosis
06/11/2009WO2009073592A2 Sulfur containing fluoroalkyl amines and isocyanates
06/11/2009WO2009070873A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity
06/11/2009US20090149625 Aromatic compound having fluorene skeleton and polyarylene having sulfonic acid group
06/11/2009US20090149510 Compositions and methods for modulating a kinase cascade
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/11/2009CA2706632A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity
06/11/2009CA2706610A1 Sulfur containing fluoroalkyl amines and isocyanates
06/10/2009CN101454279A Novel crystalline forms of armodafinil and preparation thereof
06/10/2009CN101450923A Method for preparing modafinil
06/10/2009CN100497306C Method of synthesizing E-beta-bromo-gamma-hydroxymethylenesulphone
06/09/2009US7544835 Carboxylic acid derivative and salt thereof
06/09/2009US7544699 Aryl and heteroaryl compounds, compositions, and methods of use
06/04/2009US20090143608 Sulfur containing fluoroalkyl amines and isocyanates
06/04/2009US20090143592 Glucagon Antagonists/Inverse Agonists
06/03/2009EP2064219A2 Aromatic sulfinates and sulfonyl halides, and the preparation thereof
06/03/2009CN101445486A Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
06/02/2009CA2116421C Inhibitors of hydroxyphenylpyruvate dioxygenase and an assay for identification of inhibitors
05/2009
05/28/2009WO2009066952A1 Monomer for proton-conducting polymer having acid group in side chain thereof, proton-conducting polymer prepared using the monomer, method of preparing the proton-conducting polymer, electrolyte membrane comprising the proton-conducting polymer, and membrane-electrode assembly including the electrolyte
05/28/2009US20090137773 Production Processes and Systems, Compositions, Surfactants, Monomer Units, Metal Complexes, Phosphate Esters, Glycols, Aqueous Film Forming Foams, and Foam Stabilizers
05/27/2009EP2061754A1 Biaryl and biheteroaryl compounds useful in treating iron disorders
05/27/2009EP1694627B1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
05/27/2009EP1601644B1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009CN101440052A Method for preparing meta (beta-hydroxyethyl sulfuryl) aniline
05/26/2009CA2226331C Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines
05/22/2009WO2009063427A1 Dioxoanthracene sulphonate derivatives
05/22/2009WO2008009815A3 Method for preparing aromatic sulfonates
05/22/2009CA2704630A1 Dioxoanthracene sulphonate derivatives
05/21/2009US20090131723 1-Fluoro-1,1-Bis-(Phenylsulfonyl)Methane and Production Method Thereof
05/21/2009US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease
05/21/2009US20090131411 monoamidino-containing compounds having good bioavailability and/or solubility, used as potent and specific inhibitors of blood coagulation in mammals, and as therapeutic agents for disease states characterized by coagulation disorders
05/21/2009US20090131363 Deuterated darunavir
05/20/2009EP2060562A1 Dioxoanthracene sulphonate derivatives
05/20/2009EP2059500A2 Inhibitors of zinc proteases thioaryl substituted and their use
05/20/2009EP2003116A9 Process for the production of organic oxides
05/20/2009CN101434566A Production process of methyl p-tolyl sulfone
05/19/2009US7534909 (Meth) acrylic ester compound and use thereof
05/19/2009US7534547 Fineness patterns; semiconductors, integrated circuits
05/14/2009WO2009061744A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
05/14/2009US20090124828 Unsaturated Sulfides, Sulfones, Sulfoxides and Sulfonamides Synthesis
05/14/2009CA2704473A1 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
05/13/2009EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives
05/13/2009EP1687301B1 Thiaepothilone for treating cancerous diseases
05/13/2009EP1164129B1 Industrial process for the production of diphenyl sulfone compounds
05/13/2009CN101429144A Crystalline form of (S)-2-phenylethylammonium (R)-diphenyl-methanesulphinyl-acetate
05/13/2009CN101429143A Method for producing 3,3'-diaminodiphenyl sulphone with catalytic hydrogenation of 3,3'- dinitryl diphenyl sulfone
05/13/2009CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use
05/12/2009US7531694 Condensation of 4-aminothio-phenol and 4-chloro-nitrobenzene to form 4-nitro-4'-amino-diphenyl-sulfide; oxidation of thioether with an oxidising system comprising Na2WO4 and H2O2 into; reduction of the 4-nitro-4'-amino-diphenyl-sulfone by hydrogenation; hardening agent; antibiotics
05/12/2009US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/07/2009WO2009009041A3 Compositions and methods for modulating a kinase cascade
05/07/2009US20090118532 Process for the Synthesis of Mandipropamid and Derivatives Thereof
05/06/2009EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/06/2009CN101426762A Process for improving the lubricating properties of base oils using isomerized petroleum product
05/06/2009CN100484917C Method for processing beta-sulphatoethylsulphonylaniline-2-sulphonic acid
05/05/2009US7528255 Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors
05/05/2009CA2642960A1 Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
05/05/2009CA2149298C Flk-1 is a receptor for vascular endothelial growth factor
04/2009
04/29/2009EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor
04/29/2009EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists
04/29/2009EP1438288B1 Substituted thioacetamides
04/29/2009CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity
04/29/2009CN100482626C Novel atisane compound and use thereof
04/28/2009US7524977 Process for producing fluoroalkanesulfonamide derivatives
04/28/2009US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis
04/28/2009CA2361716C Method of preparing alkylated salicylamides
04/28/2009CA2339765C Compounds and compositions for delivering active agents
04/28/2009CA2259922C Calcium receptor active compounds
04/23/2009WO2009049961A2 New no-donor aspirin derivatives
04/23/2009WO2009049845A2 Bisamide derivatives and their use as insecticidal compounds
04/23/2009US20090105452 Non-fluorescent quencher compounds and biomolecular assays
04/23/2009US20090105241 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
04/23/2009CA2702946A1 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity
04/23/2009CA2700243A1 New no-donor aspirin derivatives
04/22/2009EP1425266B1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
04/22/2009CN100480236C Process for synthesizing 2(diphenyl methyl sulfinyl) acetyl hydroxyl amide
04/22/2009CN100480172C Method for conveying crude product of thionyl chloride form low pressure to high pressure by high potential difference
04/21/2009CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
04/16/2009US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
04/14/2009US7518021 Aromatic vinyl ether compounds
04/14/2009US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis
04/14/2009CA2337797C Naaladase inhibitors useful as pharmaceutical compounds and compositions
04/09/2009WO2009045488A2 Novel crystalline forms of armodafinil and preparation thereof
04/09/2009WO2009043784A1 Cyclopropyl aryl amide derivatives and uses thereof
04/09/2009CA2699625A1 Cyclopropyl aryl amide derivatives and uses thereof
04/08/2009EP2045236A1 Thermodynamically stable crystal modification of 2-({2-chloro-4-(methylsulphonyl)-3-[(2,2,2-trifluoroethoxy)methyl]phenyl}carbonyl)cyclohexan-1,3-dione
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 159